- Home
- ATNF vs CNSP Comparison
ATNF vs CNSP Comparison
Compare ATNF & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNF
- CNSP
- Stock Information
- Founded
- ATNF 2016
- CNSP 2017
- Country
- ATNF United States
- CNSP United States
- Employees
- ATNF N/A
- CNSP N/A
- Industry
- ATNF Biotechnology: Pharmaceutical Preparations
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- ATNF Health Care
- CNSP Health Care
- Exchange
- ATNF Nasdaq
- CNSP Nasdaq
- Market Cap
- ATNF 5.0M
- CNSP 5.6M
- IPO Year
- ATNF N/A
- CNSP 2019
- Fundamental
- Price
- ATNF $3.52
- CNSP $7.62
- Analyst Decision
- ATNF
- CNSP Hold
- Analyst Count
- ATNF 0
- CNSP 1
- Target Price
- ATNF N/A
- CNSP N/A
- AVG Volume (30 Days)
- ATNF 6.6M
- CNSP 28.3K
- Earning Date
- ATNF 07-23-2025
- CNSP 08-13-2025
- Dividend Yield
- ATNF N/A
- CNSP N/A
- EPS Growth
- ATNF N/A
- CNSP N/A
- EPS
- ATNF N/A
- CNSP N/A
- Revenue
- ATNF N/A
- CNSP N/A
- Revenue This Year
- ATNF N/A
- CNSP N/A
- Revenue Next Year
- ATNF N/A
- CNSP N/A
- P/E Ratio
- ATNF N/A
- CNSP N/A
- Revenue Growth
- ATNF N/A
- CNSP N/A
- 52 Week Low
- ATNF $0.66
- CNSP $7.50
- 52 Week High
- ATNF $17.75
- CNSP $552.00
- Technical
- Relative Strength Index (RSI)
- ATNF 78.48
- CNSP 30.57
- Support Level
- ATNF $2.55
- CNSP $7.72
- Resistance Level
- ATNF $4.75
- CNSP $9.45
- Average True Range (ATR)
- ATNF 0.81
- CNSP 0.88
- MACD
- ATNF 0.21
- CNSP -0.16
- Stochastic Oscillator
- ATNF 68.24
- CNSP 3.28
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.